Relief from the symptoms of dry eye, joint pain and tendon disorders.
Friday, 18 August 2017
Sports Professionals Choose OSTENIL®
2012 London Olympics
OSTENIL was the only intra-articular sodium hyaluronate product listed in the official 2012 Olympic formulary used by medical staff.
Former international and Premiership footballers, Danny Webber and David Thompson, say that OSTENIL® injections helped them to play for longer at professional level. Please follow the links to listen to former professional players, striker Danny Webber and midfielder David Thompson talk about their experience with the treatment.
Click on the images to get to the YouTube video:
Premier League Head
of Medical & European Head Physio, Peter Friar, considers OSTENIL® as “underused in a lot of areas”, and states that he has “only ever seen a positive reaction to an OSTENIL® injection”. He noticed the positive effects of OSTENIL® injections because it actually helps to prolong the career of professional players.
Peter recommends the use of OSTENIL® “at the early onset of joint degeneration”, because it “prevents the acceleration of knee injury issues”. He even finds it “crazy that we don’t offer it more often”.
Where surgery is not feasible due to work, or when a professional athlete during the competing season has sports commitments which would make viscosupplementation a preferable treatment option in the interim, OSTENIL® is the viscosupplement of choice for knee and ankle problems.
If diagnosed in the early stages, meniscal injuries don’t necessarily require surgery. Where the damage is structurally superficial but causing pain or discomfort, patients may benefit from conservative treatments such as physiotherapy or intra-articular injections with Sodium Hyaluronate (Viscosupplementation Therapy).
But if you decide your patient may benefit from therapeutic Viscosupplementation – which product should you choose?
A recent clinical study compared the efficacy of 3 different viscosupplements in young and middle-aged patients with early-stage meniscal injuries¹. OSTENIL® PLUS was one of the viscosupplements used.
Although there were statistically significant improvements in VAS and WOMAC scores across all groups compared with baseline, numeric and trend values favoured the OSTENIL® PLUS group overall.
Other benefits associated with using OSTENIL® PLUS : A non-animal derived, optimal molecular weight, injectable Sodium Hyaluronate with Mannitol, no chemical cross linking - therefore not prone to inducing adverse reactions, licensed for use in all synovial joints, competitively priced at just £80 per syringe http://ostenil.trbchemedica.co.uk/products/ostenil-plus.
1 Dernek B, Kesiktas FN, Duymus TM, Diracoglu D, Aksoy C. Therapeutic efficacy of three hyaluronic acid formulations in young and middle-aged patients with early-stage meniscal injuries. Journal of Physical Therapy Science. 2017;29(7):1148-1153. doi:10.1589/jpts.29.1148.